169
Views
20
CrossRef citations to date
0
Altmetric
Original Article

Acute Panmyelosis with Myelofibrosis: Clinical, Immunophenotypic and Cytogenetic Study of Twelve Cases

, , , , , , & show all
Pages 1873-1879 | Received 25 Feb 2004, Published online: 03 Aug 2009

References

  • Lewis, S.M. and Szur, L. (1963) "Malignant myelosclerosis", Br. Med. J., 24, 472–474.
  • Bearman, R.M., Pangalis, G.A. and Rappaport, H. (1971) "Acute (malignant) myelosclerosis", Cancer, 43, 279–293.
  • Breton-Gorius, J., Daniel, MT., Flandrin, G.T. and Denoel, G.K. (1973) "Fine structure and peroxidase activity of circulating micromegakaryoblasts and platelets in case of acute myelofibrosis", Br. J. Haematol., 25, 331 — 339.
  • Thiele, J., Krech, R., Vykoupil, K.F. and Georgii, A. (1984) "Malignant (acute) myelosclerosis—a clinical and pathological study in 6 patients", Scand. J. Haematol., 33, 95–109.
  • Bain, B.J., Catowsky, D., O'Brien, M., Prentice, HG., Lawlor, E., Kumaran, TO., et al. (1981) "Megakaryoblastic leukemia present-ing as acute myelofibrosis—A study of four cases with the platelet—peroxidase reaction", Blood, 58, 206–213.
  • Truong, L.D., Sallem, A. and Schwartz, M.R. (1984) "Acute myelofibrosis: a report of four cases and review of the literature", Medicine, 63, 182— 187.
  • Hruban, R.H., Kuhajda, F.P. and Mann, R.B. (1987) "Acute myelofibrosis: immunohistochemical study of four cases and comparison with acute megakaryocytyc leukemia", Am. J. Clin. Path., 88, 578–588.
  • Ortuno, F., Soler, J., Vilella, R., Bordes, R., Guanyabens, C., Rubiol, E., et al. (1990) "Immunophenotype of blast cell in acute myelofibrosis", Leuk. Res., 14, 849–856.
  • Schreeder, MT., Prchal, J.T., Parmely, R.T., Carrot, A.J. and Gewirtz, AM. (1985) "An acute myeloproliferative disorder characterized by myelofibrosis and blast cells that express pheno-typic properties associated with multiple hematopotetic lineages", Am. J. Clin. Pathol., 83, 114 — 121.
  • Vardiman, J.W., Harris, N.L. and Brunninng, RD. (2002) "The world Health Organization (WHO) classification of the myeloid neoplasm", Blood, 100, 2293–2302.
  • Manoharan, A., Horsley, R. and Pitney, W. (1979) "The reticulin content of bone marrow in acute leukemia in adult", Br. J. Haematol., 43, 185–190.
  • Kraguljac, N., Marisavljevic, D., Jankovic, G., Radosevic, N., Pantie, M., Donfrid, M., et al. (2000) "Characterization of CD13 and CD33 surface antigen-negative acute myeloid leukemia", Am. J. Clin. Pathol., 114, 29–34.
  • Roche, G. and Schmitz, G. (1996) "Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies", Leukemia, 10, 877–895.
  • Key, M. (2000) Antigen retrieval. In Handbook: Immunochemical Staining Methods, edited by T. Boenish, 3rd edn. Pp 23–25. USA, Carpinteria: DAKO Corporation.
  • Bain, B.J., Barnet, D., Linch, D., Matutes, E. and Reilly, J.T. (2002) "Revised guideline on immunophenotyping in acute leukemias and chronic lymphoproliferative disorders", Clin. Lab. Haem., 24, 1— 13.
  • Dunphy, C.H., Polski, J.M., Evans, H.L. and Gardner, Li. (2001) "Evaluation of the marrow specimens with acute myelogenous leukemia for CD34, CD15, CD117 and myeloperoxidase", Arch. Pathol. Lab. Med., 125, 1063–1069.
  • Oertel, J. and Huhn, D. (2000) "Immunocytochemical methods in haematology and oncology", J. Cancer Res. Clin. OncoL, 126, 425 — 440.
  • Novak, A., Kruskic, M., Ludoski, M. and Jurukovski, V. (1994) "Rapid method for obtaining high quality chromosome banding in the study of hemopoietic neoplasia", Cancer Genet. Cytogenet., 74, 109–114.
  • Heim, S. and Mittelman, F. (1995) An International System for Human Cytogenetic Nomenclature, edited by F. Mitelman. Pp 27 — 84. Basel, Switzerland: S. Karger AG Publishers.
  • Van Slyck, E.J., Weiss, L. and Dully, M. (1970) "Chromosomal evidence for the secondary role of fibroblastic proliferation in acute myelofibrosis", Blood, 36, 729–735.
  • Terui, T., Niitsu, Y., Mahara, K., Fujsaki, Y., Urushizaki, Y., Mogi, Y., et al. (1990) "The production of transformiing growth factor-a in acute megakaryoblastic leukemia and its possible implications in myelofibrosis", Blood, 75, 1540 — 1546.
  • Cuneo, A., Kerim, S., Vandenberghe, E., Van Orshoven, A., Rodhain, J., Bosley, A., et al. (1989) "Translocation t(6; 9) occuring in acute myelofibrosis, myelodysplatic syndrome, and acute non-lymphocytic leukaemia suggests multipotent stem cell involvement", Cancer Genet. Cytogenet., 42, 209–219.
  • Dunphy, C.H., Kitchen, S., Saravia, 0. and Velasquez, W.S. (1996) "Acute myelofibrosis terminating in acute lymphoblastic leukemia: Case report and reviewof the literature", Am. J. HematoL, 51, 85 — 89.
  • Miller, KB. and Daoust, P.R. (2000) Clinical manifestations of acute myeloid leukemia. In Hematology Basic Principles and Practice, edited by R. Hoffman et al. pp 999–1010. New York. Churchill Livingstone.
  • Tien, H.F., Chou, CC., Wang, C.H., Chang, C.H. and Hsing, C.C. (1996) "Putative normal counterparts of leukaemic cells from CD7-positive acute myeloid leukaemia can be demonstrated in human haemopoietic tissues", Br. J. Haematol., 94, 501 —506.
  • Zutter, M.M., Martin, P.J., Hanke, D. and Kidd, P.G. (1990) "CD7 + acute non-lymphocytic leukemia: evidence for an early multipotential progenitor". Leuk. Res., 14, 23— 26.
  • Mitus, W.J., Coleman, N. and Kiossoglou, K.A. (1969) "Abnormal (marker) chromosomes in two patients with acute myelofibrosis", Arch. Intern. Med. (Chikago), 13, 169 — 183.
  • Shah, I., Mayeda, K., Koppitch, F., Mahmood, S. and Nemitz, B. (1982) "Karyotypic polymorphism in acute myelofibrosis", Blood, 60, 841–844.
  • Clare, N., Elson, D. and Manhoff, L. (1982) "Cytogenetic studies of peripheral myeloblasts and bone marrow fibroblasts in acute myelofibrosis", Am. J. Clin. Pathol., 77, 762–766.
  • Johansson, B., Mertens, F. and Mitelman, F. (1996) "Primary vs. secondary neoplasia-associated chromosomal abnormalities—ba-lanced rearrangements vs. genomic imbalances?", Genes, Chromo-somes & Cancer, 16, 155— 163.
  • Allen, E.F., Lunde, J.H., McNally, R. and Branda, R.E. (1996) "A case of acute myelofibrosis with complex karyotypic changes: a type of myelodysplastic syndrome", Cancer Genet. Cytogenet., 90, 24 — 28.
  • Suvajdzic, N., Marisavljevic, D., Jovanovic, V., Pantic, M., Sefer, D. and Colovic, M. (1999) "Pure red cell aplasia evolving through the hyperfibrotic myelodysplastic syndrome to the acute myeloid leukemia: some pathogenetic aspect", Hematol. Cell Ther., 41, 27 — 29.
  • Ohyashiki, K., Ohyashiki, J.H., Hojo, H., Ohtaka, M., Toyama, K., Sugita, K., et al. (1990) "Cytogenetic findings in adult acute leukemia and myeloproliferative disorders with an involvement of megakaryocyte lineage", Cancer, 65, 940–948.
  • Olah, E., Balogh, E., Kovacs, I. and Kiss, A. (1989) "Abnormalities of chromosome 1 in relation to human malignant diseases", Cancer Genet. Cytogenet., 43, 179 — 194.
  • Michaux, L., Dierlamm, J., Mecucci, C., Meeus, P., Ameye, G., Libouton, J.M., et al. (1996) "Dicentric (1;15) in Myeloid Disorders", Cancer Genet. Cytogenet., 88, 86–89.
  • Kumon, K., Kobayashi, H., Maseki, N., Sakashita, A., Sakurai, M., Tanizawa, A., et al. (1999) "Mixed-lineage leukemia with t(10;11) (p13;q21): an analysis of AF10-CALM and CALM-AF10 fusion mRNAs and clinical features", Genes Chromosomes Cancer, 25, 33 — 39.
  • Cuneo, A., Mecucci, C., Kerim, S., Vanderberghe, E., Dal CM, P., Van Orshoven, A., et al. (1989) "Multipotent stem cell involvement in megakaryoblastic leukemia: cytologic and cytogenetic evidence in 15 patients", Blood, 74, 1781 — 1790.
  • Kuss, B.J., Deeley, R.G., Cole, S.P., Willman, C.L., Kopecky, K.J., Wolman, S.R., et al. (1994) "Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: prognostic implications", Lancet, 343, 1531 — 1534.
  • Mrózek, K., Heinonen, K., de la Chapelle, A. and Bloomfield, C.D. (1997) "Clinical significance of cytogenetics in acute myeloid leukemia", Semin. Oncol., 24, 17–31.
  • Greenberg, P., Cox, C., LeBeau, M.M., Fenaux, P., Morel, P., Sans, G., et al. (1997) "International scoring system for evaluating prognosis in myelodysplastic syndromes", Blood, 89, 2079 — 2088.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.